Navigation Links
Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
Date:9/17/2009

EAST HANOVER, N.J., Sept. 17 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Valturna((R)) (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure. This is the first approval for Valturna, which is indicated for the treatment of high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (ARB) monotherapy and as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.

"This unique combination brings together the powerful blood pressure lowering effects of valsartan and aliskiren," said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division. "It offers an important additional treatment option for physicians and hypertension patients, many of whom are not at their blood pressure goal. Valturna builds upon our strong cardiovascular franchise and is consistent with our long-term commitment to developing effective and innovative therapies. It further strengthens our growing portfolio of single-pill combinations to treat high blood pressure."

Valturna combines in a single pill valsartan, the active ingredient in Diovan((R)), the number one selling branded high blood pressure medicine worldwide, and aliskiren, the active ingredient in Tekturna((R)), the only approved direct renin inhibitor (DRI). Valturna offers significantly greater blood pressure reduction than either valsartan or aliskiren alone.

"When it comes to diagnosing and treating high blood pressure, there is a real need for innovative therapies that help patients get to a healthier blood pressure range," said John Flack, M.D., Valturna investigator, and Chairman of the Department of Internal Medicine, Wayne State University, Detroit. "Now f
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
2. Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
3. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
4. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
5. Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
6. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
7. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Recovery Associates, through its multiple therapeutic ... treatment, helping men and women break free from the ... is a stimulant named for the crystalline structure it ... smoked, but it can also be injected or taken ... labs using common household ingredients and over-the-counter medicine. Crystal ...
(Date:6/19/2013)... June 19, 2013 The Semi Truck ... member is a innocent victim of a serious accident involving ... or any rural area in the US, we are urging ... response, because time really is of these essence, and it ... of truck accident legal experts, and their investigators in your ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Middle market ... 2013 across all industries as cash rich buyers seek ... differences across industries, all M&A transactions have a good ... diligence to verify the history and quality of the ... , But when due diligence involves a middle ...
(Date:6/18/2013)... Kent, WA (PRWEB) June 18, 2013 As a sponsor ... Saggau and the whole team at Lake Meridian Chiropractic want you to ... have many fond memories of the event and are excited to be ... for 24 years. We've always loved going to the Kent Splash ... year, so it only made sense to financially support this fun day.” ...
(Date:6/18/2013)... An apple a day might really ... diagnosed with breast cancer, she chose a different method ... Gave Myself Cancer, I Can Take It Away!: Alternatives ... Beauregard explains how changing her physical, mental and emotional ... been made to feel fearful when diagnosed with a ...
Breaking Medicine News(10 mins):Health News:Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates 2Health News:The Semi Truck Accident Victims Center Urges Families Of Innocent Victims Of A Semi Truck Accident In Montana, Idaho Or Wyoming To Call Them For An On The Spot Response 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:Lake Meridian Chiropractic of Kent, WA to Sponsor the Fireworks Finale at 15th Annual Fourth of July Splash 2Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2
... which could presumably play a major role in the development// ... down after examination of tumor tissue from 53 breast cancer ... which confirmed the findings. This new discovery could provide ... haunting women. ,Our improved understanding of cancer biology and genetic ...
... Japan Thursday announced a grant of $7 million for ... grant assistance would enable the Sardar Vallavbhai Patel Postgraduate ... facilities and effectively contribute towards dispensation of healthcare to ... embassy. , ,Notes concerning the project were signed ...
... doses of vitamins and minerals// are allowing themselves to ... researchers. , ,No one knows what adverse long ... the levels promoted by some alternative therapists and celebrities, ... middle-class professionals who turned to vitamins and minerals in ...
... elderly population may not be checked regularly for chronic ... in them. ,Researchers from Tufts-New England Medical Center, ... of the American Society of Nephrology that there remained ... for the geriatric patients with this health condition., ...
... on hopes for a new drug to treat women with //low ... more studies to be done on the Intrinsa patch made by ... effects the drug may induce, the Los Angeles Times reported. , ... to restore healthy sexual appetites to women struggling with low desire., ...
... attempted to commit suicide repeatedly can now be treated ... found to give better results than the other treatments ... findings were published in the current issue of JAMA. ... conducted a randomized controlled trial to determine whether a ...
Cached Medicine News:Health News:Vitamin Supplements - Good, The Bad And The Ugly 2Health News:Vitamin Supplements - Good, The Bad And The Ugly 3Health News:Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly 2Health News:FDA Diminish Hopes On ‘Female Viagra 2Health News:FDA Diminish Hopes On ‘Female Viagra 3Health News:Suicidal Tendencies May Be Treated With Cognitive Therapy 2
(Date:6/18/2013)... N.J. , June 18, 2013  Actavis, Inc. (NYSE: ... Actavis") has filed with the U.S. Securities and Exchange Commission ... Actavis, proposed acquisition of Warner Chilcott plc (NASDAQ: ... of Actavis and Warner Chilcott (the "Form S-4"). ... and Warner Chilcott have entered into a definitive ...
(Date:6/18/2013)... N.Y. , June 18, 2013  Millennium ... it has entered into an exclusive 25-year Supply ... regions with eWellness Corporation ("EWC") for its Distance ... easy to use physical therapy program is a ... and cardiovascular disease," said Chris Amandola , ...
(Date:6/18/2013)... , June 18, 2013  Women are frequently the ... unfortunately they often do not give the same priority ... kept information from their doctor because they were too ... to a recent survey conducted by Allergan and endorsed ... to bringing education, funding and research to the field ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... 4F, 5F, and 6F ... is ideal for coronary ... state-of-the-art technology and proprietary ... better responsiveness, optimal torque, ...
Medicine Products: